To this end, in order to further elucidate the influence of this NR0B1 variant on targeting genes, we preformed ChIP-sequence analysis of NR0B1 variants with an anti-NR0B1 polyclonal antibody in NCI-H295R human adrenocortical tumor cells. This evidence concerns the gene NR0B1 and adrenal cortex neoplasm.